Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Gastrointestinal effects following acupuncture at Pericardium-6 and Stomach-36 in healthy dogs: a pilot study.

Radkey DI, Writt VE, Snyder LBC, Jones BG, Johnson RA.

J Small Anim Pract. 2019 Jan;60(1):38-43. doi: 10.1111/jsap.12935. Epub 2018 Oct 3.

PMID:
30281151
2.

Self-Determination Theory and Risk Behavior in a Collectivistic Society: Preventing Reckless Driving in Urban Nepal.

Ranjit YS, Snyder LB, Hamilton MA, Rimal RN.

J Health Commun. 2017 Aug;22(8):672-681. doi: 10.1080/10810730.2017.1341569. Epub 2017 Jul 28.

PMID:
28753075
3.

Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box.

Huang H, Degnan AP, Balakrishnan A, Easton A, Gulianello M, Huang Y, Matchett M, Mattson G, Miller R, Santone KS, Senapati A, Shields EE, Sivarao DV, Snyder LB, Westphal R, Whiterock VJ, Yang F, Bronson JJ, Macor JE.

Bioorg Med Chem Lett. 2016 Sep 1;26(17):4165-9. doi: 10.1016/j.bmcl.2016.07.065. Epub 2016 Jul 28.

PMID:
27496211
4.
5.

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5.

Yang F, Snyder LB, Balakrishnan A, Brown JM, Sivarao DV, Easton A, Fernandes A, Gulianello M, Hanumegowda UM, Huang H, Huang Y, Jones KM, Li YW, Matchett M, Mattson G, Miller R, Santone KS, Senapati A, Shields EE, Simutis FJ, Westphal R, Whiterock VJ, Bronson JJ, Macor JE, Degnan AP.

ACS Med Chem Lett. 2016 Jan 4;7(3):289-93. doi: 10.1021/acsmedchemlett.5b00450. eCollection 2016 Mar 10.

6.

Effects of Buprenorphine Added to Bupivacaine Infraorbital Nerve Blocks on Isoflurane Minimum Alveolar Concentration Using a Model for Acute Dental/Oral Surgical Pain in Dogs.

Snyder LB, Snyder CJ, Hetzel S.

J Vet Dent. 2016 Jun;33(2):90-96. doi: 10.1177/0898756416657232. Epub 2016 Aug 6.

PMID:
28326977
7.

Comparison of anesthesia with a morphine-lidocaine-ketamine infusion or a morphine-lidocaine epidural on time to extubation in dogs.

Wendt-Hornickle E, Snyder LB.

Vet Anaesth Analg. 2016 Jan;43(1):86-90. doi: 10.1111/vaa.12273. Epub 2015 May 25.

PMID:
26010765
8.

Identification of glutathione conjugates of acetylene-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5.

Zhuo X, Huang XS, Degnan AP, Snyder LB, Yang F, Huang H, Shu YZ, Johnson BM.

Drug Metab Dispos. 2015 Apr;43(4):578-89. doi: 10.1124/dmd.114.061879. Epub 2015 Jan 29.

PMID:
25633841
9.

Incentives to create and sustain healthy behaviors: technology solutions and research needs.

Teyhen DS, Aldag M, Centola D, Edinborough E, Ghannadian JD, Haught A, Jackson T, Kinn J, Kunkler KJ, Levine B, Martindale VE, Neal D, Snyder LB, Styn MA, Thorndike F, Trabosh V, Parramore DJ.

Mil Med. 2014 Dec;179(12):1419-31. doi: 10.7205/MILMED-D-14-00111.

PMID:
25469962
10.

Mass media health communication campaigns combined with health-related product distribution: a community guide systematic review.

Robinson MN, Tansil KA, Elder RW, Soler RE, Labre MP, Mercer SL, Eroglu D, Baur C, Lyon-Daniel K, Fridinger F, Sokler LA, Green LW, Miller T, Dearing JW, Evans WD, Snyder LB, Kasisomayajula Viswanath K, Beistle DM, Chervin DD, Bernhardt JM, Rimer BK; Community Preventive Services Task Force.

Am J Prev Med. 2014 Sep;47(3):360-71. doi: 10.1016/j.amepre.2014.05.034. Review.

PMID:
25145620
11.

Effectiveness of mass media interventions for HIV prevention, 1986-2013: a meta-analysis.

LaCroix JM, Snyder LB, Huedo-Medina TB, Johnson BT.

J Acquir Immune Defic Syndr. 2014 Aug 15;66 Suppl 3:S329-40. doi: 10.1097/QAI.0000000000000230.

PMID:
25007204
12.

Effects of behavioral intervention content on HIV prevention outcomes: a meta-review of meta-analyses.

Johnson BT, Michie S, Snyder LB.

J Acquir Immune Defic Syndr. 2014 Aug 15;66 Suppl 3:S259-70. doi: 10.1097/QAI.0000000000000235. Review.

13.

Effect of graphic cigarette warnings on smoking intentions in young adults.

Blanton H, Snyder LB, Strauts E, Larson JG.

PLoS One. 2014 May 7;9(5):e96315. doi: 10.1371/journal.pone.0096315. eCollection 2014.

14.

Key enablers to facilitate healthy behavior change: workshop summary.

Teyhen DS, Aldag M, Centola D, Edinborough E, Ghannadian JD, Haught A, Jackson T, Kinn J, Kunkler KJ, Levine B, Martindale VE, Neal D, Snyder LB, Styn MA, Thorndike F, Trabosh V, Parramore DJ.

J Orthop Sports Phys Ther. 2014 May;44(5):378-87. doi: 10.2519/jospt.2014.0301.

PMID:
24787328
15.

Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvir.

Belema M, Nguyen VN, Bachand C, Deon DH, Goodrich JT, James CA, Lavoie R, Lopez OD, Martel A, Romine JL, Ruediger EH, Snyder LB, St Laurent DR, Yang F, Zhu J, Wong HS, Langley DR, Adams SP, Cantor GH, Chimalakonda A, Fura A, Johnson BM, Knipe JO, Parker DD, Santone KS, Fridell RA, Lemm JA, O'Boyle DR 2nd, Colonno RJ, Gao M, Meanwell NA, Hamann LG.

J Med Chem. 2014 Mar 13;57(5):2013-32. doi: 10.1021/jm401836p. Epub 2014 Feb 12.

PMID:
24521299
16.

Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons.

Belema M, Nguyen VN, Romine JL, St Laurent DR, Lopez OD, Goodrich JT, Nower PT, O'Boyle DR 2nd, Lemm JA, Fridell RA, Gao M, Fang H, Krause RG, Wang YK, Oliver AJ, Good AC, Knipe JO, Meanwell NA, Snyder LB.

J Med Chem. 2014 Mar 13;57(5):1995-2012. doi: 10.1021/jm4016203. Epub 2014 Jan 17.

PMID:
24437689
17.

Characterizations of HCV NS5A replication complex inhibitors.

O'Boyle Ii DR, Sun JH, Nower PT, Lemm JA, Fridell RA, Wang C, Romine JL, Belema M, Nguyen VN, Laurent DR, Serrano-Wu M, Snyder LB, Meanwell NA, Langley DR, Gao M.

Virology. 2013 Sep;444(1-2):343-54. doi: 10.1016/j.virol.2013.06.032. Epub 2013 Jul 27.

18.

HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivatives.

Belema M, Nguyen VN, St Laurent DR, Lopez OD, Qiu Y, Good AC, Nower PT, Valera L, O'Boyle DR 2nd, Sun JH, Liu M, Fridell RA, Lemm JA, Gao M, Knipe JO, Meanwell NA, Snyder LB.

Bioorg Med Chem Lett. 2013 Aug 1;23(15):4428-35. doi: 10.1016/j.bmcl.2013.05.040. Epub 2013 May 23.

PMID:
23803586
19.

HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activity.

St Laurent DR, Serrano-Wu MH, Belema M, Ding M, Fang H, Gao M, Goodrich JT, Krause RG, Lemm JA, Liu M, Lopez OD, Nguyen VN, Nower PT, O'Boyle DR 2nd, Pearce BC, Romine JL, Valera L, Sun JH, Wang YK, Yang F, Yang X, Meanwell NA, Snyder LB.

J Med Chem. 2014 Mar 13;57(5):1976-94. doi: 10.1021/jm301796k. Epub 2013 Apr 10.

PMID:
23573957
20.

General anesthesia in horses on fluid and electrolyte therapy.

Snyder LB, Wendt-Hornickle E.

Vet Clin North Am Equine Pract. 2013 Apr;29(1):169-78. doi: 10.1016/j.cveq.2012.11.009. Epub 2013 Feb 14. Review.

PMID:
23498051

Supplemental Content

Loading ...
Support Center